Skip to main content
. 2025 Apr 24;15:14231. doi: 10.1038/s41598-025-99010-y

Table 3.

The Pleiotropy analysis by MR-PRESSO global test.

Exposure Outcome Raw Outlier corrected Global P Number of outliers Distortion P
OR (CI%) P OR (CI%) P
Type 2 diabetes Diffuse large B-cell lymphoma 1.01 (0.89–1.14) 0.9 NA NA 0.721 NA NA
Obesity 1.08 (0.9–1.31) 0.44 NA NA 0.788 NA NA
Diabetic hypoglycemia 0.91 (0.76–1.07) 0.3 NA NA 0.31 NA NA
Hyperlipidemia 0.97 (0.86–1.08) 0.58 NA NA 0.151 NA NA
Hyperthyroidism 1.01 (0.83–1.23) 0.93 NA NA 0.18 NA NA
Type 2 diabetes Lymphoid leukaemia

1.0001

(0.9998–1.0004)

0.64 NA NA 0.174 NA NA
Obesity

0.9999

(0.9996–1.0003)

0.69 NA NA 0.96 NA NA
Diabetic hypoglycemia

1.0004

(1-1.0007)

0.07 NA NA 0.134 NA NA
Hyperlipidemia

0.9999

(0.9998–1.0001)

0.53 NA NA 0.843 NA NA
Hyperthyroidism 1.0002 (0.9998–1.0005) 0.36 NA NA 0.589 NA NA
Type 2 diabetes Follicular lymphoma 1.01 (0.83–1.23) 0.92 NA NA 0.741 NA NA
Obesity 0.8 (0.55–1.15) 0.27 NA NA 0.628 NA NA
Diabetic hypoglycemia 1.13 (0.88–1.44) 0.38 NA NA 0.338 NA NA
Hyperlipidemia 1.1 (0.95–1.26) 0.22 NA NA 0.538 NA NA
Hyperthyroidism 0.95 (0.72–1.25) 0.71 NA NA 0.09 NA NA
Type 2 diabetes Non-Hodgkin’s lymphoma 1.01 (0.92–1.11) 0.82 NA NA 0.113 NA NA
Obesity 0.98 (0.8–1.2) 0.88 NA NA 0.266 NA NA
Diabetic hypoglycemia 0.91 (0.82–1.02) 0.17 NA NA 0.111 NA NA
Hyperlipidemia 1.06 (1.01–1.11) 0.02 NA NA 0.932 NA NA
Hyperthyroidism 1.07 (0.81–1.4) 0.65 NA NA < 0.001 NA NA
Type 2 diabetes Lymph node neoplasm 0.92 (0.79–1.07) 0.27 NA NA 0.086 NA NA
Obesity 1.02 (0.75–1.39) 0.9 NA NA 0.372 NA NA
Diabetic hypoglycemia 0.95 (0.84–1.06) 0.4 NA NA 0.752 NA NA
Hyperlipidemia 1.04 (0.95–1.14) 0.38 NA NA 0.497 NA NA
Hyperthyroidism 0.99 (0.9–1.09) 0.87 NA NA 0.916 NA NA